These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11187165)

  • 21. Changes to prothrombin international normalized ratio in patients receiving hemodialysis.
    Maruyama N; Abe M; Okada K; Soma M
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):283-7. PubMed ID: 23357839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
    J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary warfarin resistance. Investigation of a rare phenomenon.
    Alving BM; Strickler MP; Knight RD; Barr CF; Berenberg JL; Peck CC
    Arch Intern Med; 1985 Mar; 145(3):499-501. PubMed ID: 3977518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical factors influencing the sensitivity to warfarin when restarted after surgery.
    Schulman S; El Bouazzaoui B; Eikelboom JW; Zondag M
    J Intern Med; 2008 Apr; 263(4):412-9. PubMed ID: 18205763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
    Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
    Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between warfarin and cranberry juice.
    Paeng CH; Sprague M; Jackevicius CA
    Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone.
    Edwin SB; Jennings DL; Kalus JS
    J Clin Pharmacol; 2010 Jun; 50(6):693-8. PubMed ID: 20081064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
    Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
    Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased anticoagulant activity of warfarin used in combination with doxifluridine.
    Nakajima M; Genda T; Suehira M; Satoh H; Miki A; Hori S; Sawada Y
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):969-72. PubMed ID: 20107800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged effects of miconazole oral gel on warfarin anticoagulation even after treatment withdrawal.
    Murakami S; Tanaka A; Ido K; Tanaka M; Araki H
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):474-6. PubMed ID: 27117040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.